Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Aquestive Therapeutics, Inc. Director's Dealing 2021

Jun 1, 2021

32552_dirs_2021-06-01_a64d91db-cbde-4af1-a298-0ea0d86ef710.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Aquestive Therapeutics, Inc. (AQST)
CIK: 0001398733
Period of Report: 2021-05-10

Reporting Person: Cochran John (N/A)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2021-05-10 Common Stock G 37500 Disposed 99486 Direct

Footnotes

F1: The reporting person gifted these shares of Common Stock to Event Facilities Fort Worth Inc. for no consideration.

F2: Price is not applicable to acquisitions or dispositions resulting from bona fide gifts.